Objectives: Lipid formulations of amphotericin B (AMBF) are widely used in the treatment of lifethreatening infections caused by Aspergillus fumigatus and Fusarium solani. We aimed to compare the immunomodulatory effects of four AMBF, deoxycholate (DAMB), liposomal (LAMB), lipid complex (ABLC) and colloidal dispersion (ABCD), on the oxidative antifungal activities of human neutrophils (PMNs) and monocytes (MNCs) against hyphae of A. fumigatus and F. solani.
Introduction
Invasive aspergillosis and fusariosis cause excessive morbidity and mortality in immunocompromised patients. Invasive aspergillosis caused by Aspergillus fumigatus is the most common cause of fungal pneumonia in immunocompromised patients. 1, 2 Fusarium spp., the most common of which is Fusarium solani, are responsible for life-threatening local or disseminated infections in severely immunocompromised patients. 3, 4 Indeed, among immunocompromised patients, mainly patients with haematological malignancies, Fusarium spp. are the second most common pathogenic filamentous fungi. 5 Aspergillus spp. and especially Fusarium spp. may be refractory to current antifungal therapies making treatment of infections caused by these fungal pathogens extremely difficult. 2, 6 The refractoriness of these infections to antifungal therapies underscores the importance of innate host defences against them.
The immune response varies with respect to the species and growth form encountered. Circulating phagocytes, particularly neutrophils (PMNs) and monocytes (MNCs), constitute the main innate host defence against fungal pathogens that cause invasive infections, including invasive aspergillosis and fusariosis. 7, 8 Oxidative pathways are among the antifungal mechanisms of PMNs and MNCs that are involved in hyphal damage. During the oxidative burst, activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase results in superoxide anion (O 2 2 ) production, a reactive oxygen intermediate released. 9 Amphotericin B is an important antifungal agent in the treatment of mycoses caused by filamentous fungi. However, due to excessive nephrotoxicity and infusion-related adverse reactions of the conventional deoxycholate amphotericin B (DAMB), 10 lipid formulations of amphotericin B, such as liposomal (LAMB), lipid complex (ABLC) and colloidal dispersion (ABCD), have been developed. These formulations have been recently shown to have immunomodulatory effects on immune response-related genes of human phagocytes 11 and on various antifungal functions resulting in inhibition of A. fumigatus in vitro. 12, 13 Little is known, however, about the effects of lipid formulations of amphotericin B on antifungal host defences against filamentous fungi and in particular against non-Aspergillus filamentous fungi. To better understand the interaction between amphotericin B formulations (AMBF) and human phagocytes in treatment of invasive aspergillosis and fusariosis, we investigated the antifungal activities of human PMNs to induce damage on A. fumigatus hyphae, and also the antifungal activities of human PMNs and MNCs to elicit a respiratory burst and to induce damage on F. solani hyphae after exposure to AMBF.
Materials and methods

Drugs and reagents
Deoxycholate amphotericin B was purchased from Bristol -Myers Squibb (La Grande Nord, Paris, France), LAMB from Gilead Sciences (San Dimas, CA, USA), ABLC from Enzon Pharmaceuticals (Piscataway, NJ, USA) and ABCD from Sequus Pharmaceuticals (Menlo Park, CA, USA). Stock solutions and final dilutions were prepared as previously described. 12 In the assays performed (described below), the final concentrations of DAMB were 1 and 5 mg/L and those of LAMB, ABLC and ABCD were 5 and 25 mg/L. The drug concentrations used were selected to be relevant to the therapeutically achievable concentrations in plasma and tissues 14, 15 as well as by preliminary experiments with a range of drug concentrations. Culture medium consisted of RPMI 1640 supplemented with 10% heat inactivated fetal calf serum, 100 U/mL penicillin and 100 mg/L streptomycin (FCM). PMA at a final concentration of 2 mg/L was used as a control stimulus of oxidative burst of MNCs and PMNs. 
Fusarium solani.
Strain F. solani NIH#26 isolated from a cancer patient with invasive fusariosis was also used. The preparation of F. solani hyphae was the same with that of A. fumigatus with the exception of a 16 h incubation for F. solani conidia to become hyphae.
Preparation of human PMNs
PMNs were purified from healthy adult donors by dextran sedimentation and Ficoll centrifugation. Whole blood was mixed with dextran to a final concentration of 1%, and the red blood cells (RBCs) were allowed to sediment for 20 min. The top layer of the biphasic solution was placed above Ficoll and centrifuged at 400 g for 20 min. The supernatant was removed, and the remaining RBCs were lysed by hypotonic shock. The PMNs were washed with HBSS 2 , resuspended in HBSS 2 and counted with a haemocytometer. The PMN concentration was adjusted to 10 6 cells/mL, and immediately after their preparation, they were incubated with 1 and 5 mg/L DAMB or 5 and 25 mg/L LAMB, ABLC and ABCD, respectively, at 378C for 2 h. PMNs were then washed and used for the functional assays.
Preparation of human MNCs
Human mononuclear cells were obtained from the blood of healthy adult volunteers and separated by centrifugation over Ficoll, as previously described. 16 Briefly, the cells were washed and resuspended in HBSS 2 . They were counted on a haemocytometer by Trypan Blue staining, and percentages of MNCs over total number of mononuclear leucocytes were calculated after staining with May-Grunwald-Giemsa. MNCs were adjusted to 10 6 cells/mL in FCM. MNC-enriched cell populations were obtained from mononuclear leucocytes by adherence on plastic surfaces in 12-well plates during incubation in a humidified CO 2 incubator at 378C for 2 h. Following adherence, the cells were washed with warm HBSS 2 and incubated in fresh FCM at 378C for 24 h prior to incubation with the drugs in order to avoid cell activation due to handling. MNCs were then incubated with 1 or 5 mg/L DAMB and 5 or 25 mg/L LAMB, ABLC and ABCD, respectively, at 378C for 22 h. They were then washed and used for the functional assays.
Cell viability
Viability of PMNs or MNCs, either untreated or amphotericin B-treated, was tested using the Trypan Blue exclusion method by counting stained (dead) versus unstained (alive) cells on a haemocytometer. Viability was .95% in all experiments.
Hyphal damage assay
Hyphal damage was assessed by a modified method of the XTT colorimetric assay. 17 During this assay, tetrazolium salts are taken up by viable hyphae and are reduced by mitochondrial dehydrogenase of the fungi to coloured tetrazolium products that are determined spectrophotometrically. Pre-treated PMNs were added to 10 4 hyphae in HBSS 2 in each well at effector cell:target (E:T) ratios of 5:1 and 10:1 and incubated for 2 h. Similarly, pre-treated MNCs were added to 10 4 hyphae at E:T ratios of 10:1 and 20:1 and incubated for 2 h. After the 2 h of incubation at 378C with 5% CO 2 , PMNs or MNCs were lysed by washing with H 2 O three times before adding 150 mL of a solution containing 0.25 g/L XTT plus 40 mg/L coenzyme Q. After incubation at 378C with 5% CO 2 for 1 h, hyphal damage was assessed at 450 nm with a reference wavelength of 690 nm. Antihyphal activity was calculated according to the following formula: percent hyphal damage ¼ (1 2 X/C) Â 100, where X is the absorbance of experimental wells and C is the absorbance of control wells with hyphae only. 18 Superoxide anion production
2 ) release was assessed by a modification of a previously described cytochrome c reduction method.
19 YNB broth was replaced by 100 mL of HBSS þ in all wells. Cytochrome c was added to all wells at a final concentration of 65 mM, and PMNs or MNCs that had been pre-treated with drugs for 2 or 22 h, respectively, were added to wells containing 2 Â 10 5 hyphae at an E:T ratio of 1:1. Control (untreated) PMNs or MNCs were also added to wells containing 2 Â 10 5 hyphae at an E:T ratio of 1:1. PMA was added to certain wells without hyphae together with untreated PMNs or MNCs as a positive control of O 2 2 production. Plates were incubated at 378C with 5% CO 2 for 1 h. Aliquots of 200 mL were assessed for cytochrome c reduction spectrophotometrically at 550 nm with a reference wavelength of 690 nm.
Hyphal susceptibility to hydrogen peroxide
Susceptibility of A. fumigatus and F. solani hyphae to H 2 O 2 was assessed by a modification of a previously described method.
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Suspensions of both fungi containing 10 5 conidia/mL in YNB were incubated to become hyphae. They were then incubated with different H 2 O 2 concentrations of 0, 50, 100 and 200 mM H 2 O 2 solutions for 10 min. Each hyphal suspension was then washed with H 2 O twice before adding 150 mL of a solution containing 0.25 mg/mL XTT plus 40 mg/L coenzyme Q. After incubation at 378C with 5% CO 2 for 30 min, hyphal damage was assessed at 450 nm with a reference wavelength of 690 nm. Antihyphal activity was calculated according to the following formula: percent hyphal damage ¼ (1 2 X/C) Â 100, where X is the absorbance of experimental wells and C is the absorbance of control wells with hyphae only. 18 
Statistical analysis
Each experiment investigating hyphal damage and O 2 2 production was performed with PMNs or MNCs of one blood donor using duplicate wells for each condition. For each set of functional assays (hyphal damage by PMNs and MNCs at each E:T ratio and O 2 2 production), five experiments were performed. The average value of these replicate wells was taken as the value for a blood donor/ experiment. These values were then used in the data analysis to calculate the mean + SE of all the donors at the same condition. Comparisons between drug-treated and untreated PMNs or MNCs and also between high and low AMBF concentrations as well as other conditions were performed using one-way analysis of variance (ANOVA) with Dunnett as the post-test for multiple comparisons. A P value of ,0.05 indicated statistical significance.
Results
Hyphal damage induced by PMNs on A. fumigatus
Pre-treatment of PMNs with both low and high concentrations of all AMBF for 2 h resulted in significantly increased PMN-induced hyphal damages as compared with hyphal damage induced by PMNs alone at both E:T ratios of 5:1 and 10:1 (P , 0.01; Figure 1a and b) .
Among the low concentrations of AMBF at an E:T ratio of 5:1, ABLC (5 mg/L)-pre-treated PMNs tended to exhibit the largest increase in hyphal damage as compared with PMNs alone (P , 0.01). By comparison, among the high concentrations of AMBF, DAMB (5 mg/L)-pre-treated PMNs tended to exhibit the largest increase in hyphal damage as compared with PMNs alone (Figure 1a ; P , 0.01). By analogy, at an E:T ratio of 10:1, ABLC (5 mg/L) among the low concentrations and DAMB (5 mg/L) among the high concentrations of AMBF again tended to exhibit the largest increase in hyphal damages as compared with PMNs alone (Figure 1b ; P , 0.01).
Of note, significant differences in hyphal damage induced by PMNs pre-treated with all AMBF and then incubated with A. fumigatus at an E:T ratio of 5:1 were observed between high and low concentrations of the drugs (Figure 1a ). By comparison, at an E:T ratio of 10:1, significant differences were observed only between high and low concentrations of DAMB and LAMB with LAMB-pre-treated PMNs exhibiting lower hyphal damage than the corresponding DAMB pre-treatment (Figure 1b ; P 0.002).
Hyphal damage induced by PMNs on F. solani
Pre-treatment of PMNs with either low or high concentrations of virtually all AMBF for 2 h resulted in significantly increased PMN-induced hyphal damages as compared with PMNs alone at both E:T ratios of 5:1 and 10:1 (P , 0.05; Figure 2a and b) .
PMNs pre-treated with DAMB at high concentrations and incubated with F. solani hyphae at either 5:1 or 10:1 E:T ratios resulted in the largest increases of hyphal damage among all four AMBF. In particular, PMNs pre-treated with 5 mg/L DAMB at an E:T ratio of 5:1 resulted in 90.7 + 2.1% hyphal damage as compared with 12.2 + 2.5% of PMNs alone (Figure 2a ; P , 0.001). At an E:T ratio of 10:1, PMNs pretreated with 5 mg/L DAMB resulted in a relatively very high percentage of hyphal damage as compared with PMNs alone (96 + 2% versus 22.3 + 4.1%, respectively, P , 0.001; Figure 2b ).
Significant differences were also observed in hyphal damage against F. solani induced by PMNs pre-treated with AMBF and then incubated with F. solani at an E:T ratio of 5:1 between high and low concentrations of DAMB, LAMB and ABCD. At an E:T ratio of 10:1, significant differences were observed between high and low concentrations of DAMB and LAMB only. The largest difference between high and low concentrations of AMBF was noticed with LAMB at an E:T ratio of 10:1 (Figure 2b ; P , 0.0001).
Hyphal damage induced by MNCs on F. solani Among all four AMBF, pre-treatment of MNCs with both concentrations of ABLC and subsequent incubation with F. solani hyphae at both E:T ratios resulted in the largest increases Significant differences in hyphal damage against F. solani induced by pre-treated MNCs at an E:T ratio of 10:1 were also observed between high and low concentrations of DAMB, LAMB and ABCD. In particular, treatment of MNCs with low (1 mg/L) and high (5 mg/L) concentrations of DAMB resulted in significant differences between these concentrations (P ¼ 0.0002). In addition, the same trend was observed when MNCs were pre-treated with 5 and 25 mg/L LAMB (P ¼ 0.014) and ABCD (P ¼ 0.018). At an E:T ratio of 20:1, significant differences also were observed between high and low concentrations of DAMB (P ¼ 0.003) and LAMB (P ¼ 0.046).
Superoxide anion production by PMNs
Aspergillus fumigatus. In general, neither low nor high concentrations of AMBF showed significant changes in the O 2 2 production in response to hyphae of both fungi as compared with 
/10
6 PMN/h, respectively; P , 0.01).
Fusarium solani. Hyphae of F. solani stimulated O 2 2 production to a smaller degree (Figure 4) 
Discussion
Although A. fumigatus and F. solani are both opportunistic filamentous fungi with great mortality, they have distinct characteristics with regard to their biology, drug susceptibility and interaction with host defences, and may thus have different susceptibilities to PMNs and/or MNCs under the influence of specific or all AMBF. In this study, we have demonstrated that: (i) deoxycholate and lipid formulations of amphotericin B enhance antifungal activities of both types of phagocytes, PMNs and MNCs, against A. fumigatus and F. solani, as evidenced by phagocyte-induced hyphal damage; (ii) the activity of a given AMBF in increasing the hyphal damage varies as a function of phagocyte and organism; (iii) there are no substantial E:T ratiodependent differences in AMBF enhancement; (iv) there is, however, an AMBF concentration dependency of AMBF effects; and (v) of note, interaction between AMBF and human phagocytes is not accompanied with enhanced oxidative burst as shown by unchanged or reduced O 2 2 production by pre-treated phagocytes in response to hyphae of these fungal species.
In a previous report, we presented data on the effects of the four AMBF on the hyphal damage induced by MNCs and on O 2 2 production elicited by MNCs in response to A. fumigatus.
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In this report, we expand our studies on the effects of AMBF on the hyphal damage induced by PMNs in response to A. fumigatus, and on the effects of AMBF on the hyphal damage induced by PMNs and MNCs and on O 2 2 production elicited by PMNs and MNCs in response to F. solani.
This study indicates that the immune response against A. fumigatus and F. solani, as evidenced by hyphal damage activity, may be species dependent. Taken the results of this study and those of other studies together, 12,13 the effects of AMBF on the antihyphal activity of PMNs against F. solani were somewhat lower than the effects on the antihyphal activity of PMNs against A. fumigatus. The strains of Aspergillus and Fusarium that have been used are typical isolates of these organisms and are well characterized in terms of their basic host -pathogen interaction, pathogenicity and drug susceptibility. 21 F. solani seems to be more resistant to oxidative antifungal mechanisms as shown in the experiments of hyphal susceptibility to H 2 O 2 , as compared with A. fumigatus hyphae. A possible explanation is that F. solani hyphae tend to have decreased susceptibility to antifungal peptides or to other non-oxidative antifungal mechanisms as compared with A. fumigatus hyphae. 21 ABLC-pre-treated MNCs exhibited a trend towards the highest degree of antihyphal activity against A. fumigatus and F. solani as shown in this study and our previous study. 12 By comparison, PMNs result in more variable degrees of hyphal damage of the two organisms after incubation with the four AMBF. The antifungal activity of ABLC-pre-treated MNCs among the AMBF does not appear to be due to a direct effect on antifungal MNC function by enhanced expression of a combination of immunoenhancing cytokines (i.e. TNF-a or IL-1b), since these cytokines are not enhanced by ABLC. 11 Release of lipases by A. fumigatus or F. solani breaking down the lipid complex ribbon structures of intracellular ABLC could cause an enhanced delivery of amphotericin B and fungicidal products of the MNC to the hyphal membrane, which might account for the enhanced antifungal effect observed. 12, 18 However, it is unclear why ABLC does not consistently have a similarly pronounced effect on PMNs against the two fungi. The immunomodulatory effect of AMBF on hyphal damage against the two fungi is concentration dependent. We used two concentrations of each drug, a low concentration and a high concentration, that are clinically achievable in plasma and/or tissue. Our data support the notion that a higher concentration may have a better immunomodulatory effect on PMN/MNC antifungal function.
The mechanism underlying the immunomodulatory effects of AMBF may be related to their interaction with Toll-like receptors (TLRs). 22, 23 It has been previously shown that DAMB as well as LAMB induce signal transduction via TLR2 on the surface of phagocytes. Through an NF-kB-mediated pathway, these formulations modify cytokine expression and antifungal function of phagocytes. AMBF may also affect other molecules on the surface or in the cytoplasm of effector cells ultimately modulating their antifungal function. 24, 25 In addition, amphotericin B through TLR2 signalling activates oxidative mechanisms of killing, whereas the liposomes through TLR and intracellular pathogen-associated molecular patterns (PAMPs) polarize PMNs to non-oxidative mechanisms of killing, which are more important for hyphal versus conidial damage. 24 The reported effects of AMBF on O 2 2 production by human phagocytes have been variable. 12,26 -28 In the present study, none of the AMBF affected O 2 2 release from pre-treated MNCs and PMNs in response to hyphae of A. fumigatus and F. solani. The exception was pre-treated PMNs with DAMB at 1 mg/L and ABCD at 25 mg/L, which significantly reduced the production of O 2 2 in response to A. fumigatus hyphae. This suppressive effect may be due to the binding of DAMB and ABCD to sterols of MNCs and subsequent cell membrane injury. The same suppressive effect has been found to occur with high concentrations of DAMB in previous studies. 28, 29 In our previous report, 12 MNCs pre-treated with a high concentration (25 mg/L) of ABLC significantly reduced the production of O 2 2 in response to serum-opsonized A. fumigatus hyphae. This finding probably suggests that, in addition to DAMB, lipid amphotericin B formulations, including ABLC and ABCD, although they are better tolerated and less toxic antifungal agents, can also cause subsequent cell membrane injury especially at high concentrations.
The remarkable finding of increased hyphal damage with a suppressed O 2 2 production after treatment of phagocytes with certain AMBF is in agreement with the result of our previous study. 12 Although there is no definitive explanation, one can speculate that while O 2 2 constitutes the first reactive oxygen intermediate released during the oxidative burst, it must act within a short period of time, rapidly leading to more powerful oxidizing species production, such as H 2 O 2 and H 2 O 2 -dependent intracellular intermediates. 30 Therefore, the increased phase during its measurement may be missed. Additionally, a dissociation of O 2 2 from H 2 O 2 levels may occur through differential expression of enzymes catalyzing reactive oxygen intermediates such as dismutase and myeloperoxidase. 31 Furthermore, enhanced hyphal damage without a concomitant increase in O 2 2 production may be related to modulation of antimicrobial peptides found within the granules of phagocytes. Phagocyteinduced hyphal damage is mediated by the oxidative burst in combination with complementary non-oxidative mechanisms, the latter consisting of a variety of antimicrobial peptides. 32 Some of these antimicrobial peptides, including azurocidin, lactoferrin and lysozyme, exhibit antifungal activity and can be found in high concentrations at the site of infection. Incubation of hyphae with cationic peptides and other granule constituents results in the release of cell wall glycoproteins, thereby indicating hyphal damage. 33 This hypothesis may suggest a potential role of amphotericin B-induced modulation of other fungicidal mechanisms, perhaps non-oxidative, on the immune response to fungi.
In conclusion, we have demonstrated that AMBF, at clinically relevant ranges of concentrations, enhance antihyphal activity of human phagocytes, PMNs or MNCs, against A. fumigatus and F. solani. This augmentation of the antifungal function of human phagocytes is not associated with significantly augmented O 2 2 production suggesting a critical role for other innate immune mechanisms, perhaps non-oxidative. Although further studies on the molecular mechanisms of these interactions are required, differential immunomodulatory effects of AMBF may be of clinical significance in the management of invasive aspergillosis and fusariosis.
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